SAGE
First Trust Advisors’s Sage Therapeutics SAGE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-74,485
| Closed | -$1.53M | – | 2426 |
|
2023
Q3 | $1.53M | Buy |
74,485
+36,643
| +97% | +$754K | ﹤0.01% | 1797 |
|
2023
Q2 | $1.78M | Buy |
37,842
+30,064
| +387% | +$1.41M | ﹤0.01% | 1769 |
|
2023
Q1 | $326K | Sell |
7,778
-37,993
| -83% | -$1.59M | ﹤0.01% | 2226 |
|
2022
Q4 | $1.75M | Buy |
45,771
+36,917
| +417% | +$1.41M | ﹤0.01% | 1751 |
|
2022
Q3 | $347K | Buy |
+8,854
| New | +$347K | ﹤0.01% | 2313 |
|
2022
Q2 | – | Sell |
-844,652
| Closed | -$28M | – | 2587 |
|
2022
Q1 | $28M | Buy |
844,652
+33,218
| +4% | +$1.1M | 0.03% | 682 |
|
2021
Q4 | $34.5M | Buy |
811,434
+222,395
| +38% | +$9.46M | 0.03% | 610 |
|
2021
Q3 | $26.1M | Buy |
589,039
+178,286
| +43% | +$7.9M | 0.03% | 677 |
|
2021
Q2 | $23.3M | Buy |
410,753
+160,865
| +64% | +$9.14M | 0.03% | 710 |
|
2021
Q1 | $18.7M | Buy |
249,888
+82,731
| +49% | +$6.19M | 0.02% | 734 |
|
2020
Q4 | $14.5M | Buy |
+167,157
| New | +$14.5M | 0.02% | 725 |
|